Prescription drugs Januvia, Janumet, Byetta, Bydureon and Victoza are commonly used to treat Type 2 diabetes, but studies and correlations have shown dangerously high risks for deadly side effects including pancreatic cancer and pancreatitis. This has raised very serious questions about whether the drugs’ risks outweigh their benefits and what the manufacturers of the drugs may or may not have known of these risks.
According to attorneys for the plaintiffs, the defendants knew or should have known that consumers would foreseeably and needlessly suffer injury or death as a result of defendants’ failures, still defendants failed to provide timely and adequate warnings to physicians, pharmacies, and consumers about the foreseeable risks of pancreatic cancer and pancreatitis.
Allegations in complaints against this group of drugs and their makers include:
The drugs at issue are: Januvia brand sitagliptin and Janumet, a combination of Januvia and metformin, made by Merck Sharpe & Dohme Corp.; Byetta brand exenatide, made by Amylin Pharmaceuticals LLC and co-promoted by AstraZeneca; Victoza brand liraglutide, made by Novo Nordisk Inc.; and Tradjenta brand linagliptin, made by Eli Lilly and Co. The drugs are glucagon-like peptide-1 (GLP-1) receptor agonists or dipeptidyl peptidase-4 (DPP-4) inhibitors and are sometimes described as incretin mimetics.
The drugs are prescribed to people with type 2 diabetes to help control blood glucose levels.
The defendants twice moved for preemption summary judgment, arguing that it would be impossible for them to comply with federal labeling requirements and state tort law, given the FDA’s opinions regarding a causal association between the drugs and pancreatic cancer.
The plaintiffs countered that the FDA did not expressly reject a label reference to pancreatic cancer and, therefore, under U.S. Supreme Court case law, there is no “clear evidence” that the agency would have rejected such a warning.
Did you or a loved one suffer Pancreatic Cancer while taking Diabetes Drugs Januvia, Janumet, Byetta or Victoza?
Find out if you may qualify for compensationFind Out More
Consumer Safety Watch offers safety advocate services and attorney referral services for patients throughout the United States including the states of Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin and Wyoming.
Consumer Safety Watch offers consumer safety advocate services or can help you find an attorney throughout the United States including the following cities: Albuquerque, NM; Arlington, TX; Atlanta, GA; Austin, TX; Baltimore, MD; Boston, MA; Charlotte, NC; Chicago, IL; Cleveland, OH; Colorado Springs, CO; Columbus, OH; Dallas, TX; Denver, CO; Detroit, MI; Fresno, CA; Fort Worth, TX; Indianapolis, IN; Honolulu, HI; Houston, TX; Jacksonville, FL; Kansas City, KS; Kansas City, MO; Las Vegas, NV; Long Beach, CA; Los Angeles, CA; Louisville, KY; Memphis, TN; Mesa, AZ; Miami, FL; Miami, OH; Milwaukee, WI; Minneapolis, MN; Nashville, TN; New York City, NY; Oakland, CA; Oklahoma City, OK; Omaha, NE; Philadelphia, PA; Phoenix, AZ; Pittsburgh, PA; Portland, OR; Sacramento, CA; San Antonio, Tx; San Diego, CA; San Francisco, CA; San Jose, CA; Seattle, WA; St. Louis, MO; Tampa, FL; Tucson, AZ; Tulsa, Virginia Beach, VA; Washington, DC; Wichita, KS.
This website is not affiliated with any pharmaceutical or medical device company or any trademarked product. Results are not guaranteed. This website provides a free matching service and is not responsible for information or services from third party providers. Consumer Safety Watch is not a law firm. Every case is different and services available can vary.